-
Publication Venue For
-
Influence of Cardiac Remodeling on Clinical Outcomes in Patients With Aortic Regurgitation..
81:1885-1898.
2023
-
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure.
2023
-
CDC-WONDER Database Analysis of COVID-19 and Cardiovascular Disease-Related Mortality..
81:1743-1745.
2023
-
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial..
81:1697-1709.
2023
-
Reply: Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiogenic Shock and Severe Mitral Regurgitation..
81:e131.
2023
-
Critical Care Enrichment During Advanced Heart Failure Training..
81:1296-1299.
2023
-
Early Lead Extraction for Infected Implanted Cardiac Electronic Devices: JACC Review Topic of the Week..
81:1283-1295.
2023
-
Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week..
81:771-779.
2023
-
Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation..
81:636-648.
2023
-
Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair..
81:521-532.
2023
-
Prevalence and Professional Impact of Mental Health Conditions Among Cardiologists..
81:574-586.
2023
-
TEER Programs at Mitral Surgery Centers: When One Hand Washes the Other..
81:533-536.
2023
-
Albuminuria and Heart Failure: JACC State-of-the-Art Review..
81:270-282.
2023
-
Implementation of High-Sensitivity Cardiac Troponin Assays in the United States..
81:207-219.
2023
-
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection..
81:224-234.
2023
-
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease..
80:2301-2310.
2022
-
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses..
80:2171-2183.
2022
-
2022 ACC Health Policy Statement on Career Flexibility in Cardiology: A Report of the American College of Cardiology Solution Set Oversight Committee..
80:2135-2155.
2022
-
Expanding the Molecular Autopsy to Uncover Occult Cardiomyopathy: Concealed to Revealed..
80:2069-2071.
2022
-
Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock..
80:2072-2084.
2022
-
Coronary Calcium Scoring Improves Risk Prediction in Patients With Suspected Obstructive Coronary Artery Disease..
80:1965-1977.
2022
-
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure..
80:1775-1784.
2022
-
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction..
80:1705-1717.
2022
-
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes..
80:1735-1747.
2022
-
Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week..
80:1647-1659.
2022
-
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction..
80:1529-1541.
2022
-
Reply: Does the Solution Only Lie in the Size of the Aorta?.
80:e131.
2022
-
Reply: High-Dose Statins Increase Adverse Events and Do Not Improve Survival..
80:e127.
2022
-
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction..
80:1302-1310.
2022
-
Ventricular Pacing in Single Ventricle Circulation: Making the Best of a Difficult Situation..
80:915-917.
2022
-
Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial..
80:755-765.
2022
-
Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy..
80:766-778.
2022
-
Persistent Racial/Ethnic Disparities in Cardiology Trainees in the United States..
80:276-279.
2022
-
Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study..
80:22-32.
2022
-
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations..
80:63-88.
2022
-
2022 ACC Health Policy Statement on Building Respect, Civility, and Inclusion in the Cardiovascular Workplace: A Report of the American College of Cardiology Solution Set Oversight Committee..
79:2153-2184.
2022
-
Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway: Statins Prevent Heart Failure?.
79:2034-2036.
2022
-
Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week..
79:2058-2068.
2022
-
Location of Aortic Enlargement and Risk of Type A Dissection at Smaller Diameters..
79:1890-1897.
2022
-
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation..
79:1785-1798.
2022
-
Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison..
79:1849-1857.
2022
-
High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S..
79:1802-1813.
2022
-
Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week..
79:1858-1869.
2022
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
79:1757-1780.
2022
-
Impact of Polyvascular Disease and Diabetes on Limb and Cardiovascular Risk in Peripheral Artery Disease..
79:1781-1783.
2022
-
Association of Left Atrial Structure and Function With Heart Failure in Older Adults..
79:1549-1561.
2022
-
Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short..
79:1474-1476.
2022
-
Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7..
79:1506-1518.
2022
-
Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?.
79:1382-1384.
2022
-
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7..
79:1407-1425.
2022
-
Patients With Myocarditis Associated With COVID-19 Vaccination..
79:1317-1319.
2022
-
Childbearing Among Women Cardiologists: The Interface of Experience, Impact, and the Law..
79:1076-1087.
2022
-
Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients..
79:1050-1059.
2022
-
Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action..
79:861-863.
2022
-
Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review..
79:819-836.
2022
-
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial..
79:651-661.
2022
-
Training in Critical Care Cardiology Within Critical Care Medicine Fellowship: A Novel Pathway..
79:609-613.
2022
-
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention..
79:417-427.
2022
-
Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review..
79:482-503.
2022
-
Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week..
79:504-510.
2022
-
Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure..
79:355-368.
2022
-
For TAVR, Home Is Where the Heart Is..
79:145-147.
2022
-
Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy..
78:2518-2532.
2021
-
Aortic Valve Replacement and Patient-Centered Implementation: To Boldly Go Where No Device Has Gone Before..
78:2173-2176.
2021
-
Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review..
78:2092-2105.
2021
-
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI..
78:2060-2072.
2021
-
In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction..
78:2004-2012.
2021
-
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD..
78:1768-1778.
2021
-
Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure..
78:1751-1752.
2021
-
Perspectives of Racially and Ethnically Diverse U.S. Cardiologists: Insights From the ACC Professional Life Survey..
78:1746-1750.
2021
-
Reply: When Will We Stop Debating on the Value of TEE in CABG?.
78:e139-e140.
2021
-
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT..
78:1499-1507.
2021
-
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week..
78:1550-1563.
2021
-
Investigator-Reported Versus Adjudicated Clinical Events: 2 Versions of the Truth?.
78:1538-1540.
2021
-
Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review..
78:1166-1187.
2021
-
Should Cardiovascular Preventive Therapy Be Over-the-Counter?.
78:1124-1126.
2021
-
Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review..
78:931-956.
2021
-
Dissemination of Transcatheter Aortic Valve Replacement in the United States..
78:794-806.
2021
-
Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art Review..
78:827-839.
2021
-
Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial..
78:757-759.
2021
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol..
78:421-433.
2021
-
Molecular Aspects of Lifestyle and Environmental Effects in Patients With Diabetes: JACC Focus Seminar..
78:481-495.
2021
-
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure..
78:330-343.
2021
-
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial..
78:317-326.
2021
-
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities..
78:126-138.
2021
-
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF..
78:97-108.
2021
-
Transesophageal Echocardiography in Patients Undergoing Coronary Artery Bypass Graft Surgery..
78:112-122.
2021
-
Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans..
78:89-91.
2021
-
Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week..
78:66-76.
2021
-
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease..
77:3016-3027.
2021
-
Preventing and Managing Bleeding With Anticoagulation for Atrial Fibrillation..
77:3002-3004.
2021
-
Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization..
77:2867-2869.
2021
-
Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review..
77:2693-2716.
2021
-
Time for a Renewed Focus on the DASH-Low Sodium Diet..
77:2635-2637.
2021
-
Survival After Implantable Cardioverter-Defibrillator Shocks..
77:2453-2462.
2021
-
Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace..
77:2398-2409.
2021
-
Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review..
77:2432-2447.
2021
-
Group Medical Visit and Microfinance Intervention for Patients With Diabetes or Hypertension in Kenya..
77:2007-2018.
2021
-
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week..
77:1922-1933.
2021
-
Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction..
77:1952-1953.
2021
-
Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5..
77:1813-1822.
2021
-
Team-Based Care of Women With Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 1/5..
77:1763-1777.
2021
-
Infective Endocarditis in Patients on Chronic Hemodialysis..
77:1629-1640.
2021
-
Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care..
77:1408-1411.
2021
-
Primary Versus Staged Neonatal Repair of Symptomatic Tetralogy of Fallot: Time to Randomize?.
77:1107-1109.
2021
-
Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States..
77:1023-1025.
2021
-
Pre-Diabetes and Stroke in Patients With Atrial Fibrillation: When Risk Begets Risk..
77:885-887.
2021
-
2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee..
77:811-825.
2021
-
Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence..
77:709-712.
2021
-
Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation..
77:713-724.
2021
-
Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs..
77:544-555.
2021
-
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines..
77:e25-e197.
2021
-
Prognostication for Sudden Cardiac Arrest Patients Achieving ROSC..
77:372-374.
2021
-
Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?.
77:268-270.
2021
-
Preventing Atrial Fibrillation After Cardiac Surgery: What Matters Most..
77:68-70.
2021
-
Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry..
76:2940-2951.
2020
-
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study..
76:2982-3021.
2020
-
Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review..
76:2878-2894.
2020
-
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review..
76:2650-2670.
2020
-
Incorporating Coronary Calcification Into Pre-Test Assessment of the Likelihood of Coronary Artery Disease..
76:2421-2432.
2020
-
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement..
76:2492-2516.
2020
-
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel..
76:2368-2378.
2020
-
Cardio-Oncology Education and Training: JACC Council Perspectives..
76:2267-2281.
2020
-
Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors..
76:1919-1930.
2020
-
Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation..
76:2038-2039.
2020
-
Anticoagulation in COVID-19: It Is Time for High-Quality Evidence..
76:1827-1829.
2020
-
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial..
76:1830-1843.
2020
-
Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates..
76:1717-1718.
2020
-
Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery Disease..
76:1536-1547.
2020
-
Diversity and Inclusion: Central to ACC's Mission, Vision, and Values..
76:1494-1497.
2020
-
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel..
76:1468-1483.
2020
-
Increasing Diversity in Cardiology: It Will Take a Village..
76:1223-1225.
2020
-
Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists..
76:1034-1048.
2020
-
Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease..
76:945-957.
2020
-
RESPONSE: The Time for Action Is Now..
76:999-1000.
2020
-
Identification of Undetected Monogenic Cardiovascular Disorders..
76:797-808.
2020
-
Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond..
76:886-888.
2020
-
Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults..
76:653-664.
2020
-
Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week..
76:580-589.
2020
-
Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review..
76:435-450.
2020
-
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT..
76:405-415.
2020
-
Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease..
76:351-352.
2020
-
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI..
76:162-171.
2020
-
COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week..
76:72-84.
2020
-
Reply: Specifics of Dose Modification in ARISTOTLE..
76:128-129.
2020
-
Publication Rates of Heart Failure Clinical Trials Remain Low..
75:3151-3161.
2020
-
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial..
75:3105-3118.
2020
-
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership..
75:3177-3183.
2020
-
ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology..
75:3078-3084.
2020
-
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy..
75:2649-2660.
2020
-
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients..
75:2711-2722.
2020
-
Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries..
75:2446-2458.
2020
-
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI..
75:2372-2375.
2020
-
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial..
75:2297-2308.
2020
-
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial..
75:2110-2118.
2020
-
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI..
75:1743-1754.
2020
-
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan..
75:1644-1656.
2020
-
A Biomarker Approach to Understanding HFpEF..
75:1296-1298.
2020
-
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease..
75:1299-1308.
2020
-
Predicting In-Hospital Survival in Acute Type A Aortic Dissection Medically Treated..
75:1360-1361.
2020
-
Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial..
75:1145-1155.
2020
-
Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review..
75:1178-1195.
2020
-
Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin..
75:835-837.
2020
-
In-Hospital Outcomes and Discharge Medication Use Among Patients With Critical Limb Ischemia Versus Claudication..
75:704-706.
2020
-
Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease..
75:608-617.
2020
-
Addressing the Menace of Enterococcal Endocarditis..
75:495-497.
2020
-
Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization..
75:498-508.
2020
-
New Approaches to Conducting Randomized Controlled Trials..
75:556-559.
2020
-
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography..
75:289-300.
2020
-
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome..
75:133-144.
2020
-
Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus..
74:3176-3178.
2019
-
Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States..
74:2955-2965.
2019
-
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes..
74:3013-3022.
2019
-
Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis..
74:2833-2842.
2019
-
Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction..
74:2466-2477.
2019
-
Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events..
74:2047-2055.
2019
-
2019 ACC Health Policy Statement on Cardiologist Compensation and Opportunity Equity..
74:1947-1965.
2019
-
Community Health Workers Improve Linkage to Hypertension Care in Western Kenya..
74:1897-1906.
2019
-
Trends in Place of Death for Individuals With Cardiovascular Disease in the United States..
74:1943-1946.
2019
-
10 Recommendations to Enhance Recruitment, Retention, and Career Advancement of Women Cardiologists..
74:1839-1842.
2019
-
Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain..
74:1741-1755.
2019
-
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review..
74:1823-1838.
2019
-
Overcoming the Risk-Treatment Paradox for Non-ST-Segment Elevation Acute Coronary Syndromes..
74:1462-1464.
2019
-
Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction..
74:1426-1427.
2019
-
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial..
74:1167-1176.
2019
-
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement..
74:1190-1200.
2019
-
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery..
74:1177-1186.
2019
-
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction..
74:1205-1217.
2019
-
Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week..
74:1107-1115.
2019
-
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial..
74:1057-1068.
2019
-
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society..
74:932-987.
2019
-
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
74:e51-e156.
2019
-
Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
74:988-1008.
2019
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction..
74:601-612.
2019
-
Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)..
74:699-711.
2019
-
Incorporating Shared Decision Making and Palliative Care Into Cardiogenic Shock Pathways..
74:591-592.
2019
-
Reply: Standardized and Tailored Approach to Therapies for Cardiogenic Shock..
74:593-594.
2019
-
2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee..
74:377-402.
2019
-
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I..
74:271-282.
2019
-
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel..
74:238-256.
2019
-
Evolving the Hospital Readmissions Reduction Program: A Call for Peace, Happiness, and Improved Patient-Centered Outcomes..
74:235-237.
2019
-
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
74:104-132.
2019
-
Cardiac Allograft Vasculopathy: A Formidable Foe..
74:52-53.
2019
-
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review..
74:83-99.
2019
-
Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention..
74:70-79.
2019
-
Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients..
73:3281-3291.
2019
-
Burnout and Career Satisfaction Among U.S. Cardiologists..
73:3345-3348.
2019
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:e285-e350.
2019
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:3168-3209.
2019
-
Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals..
73:3118-3131.
2019
-
Heart Failure Management Under Pressure..
73:3064-3066.
2019
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:3210-3227.
2019
-
Risk of Total Events With Icosapent Ethyl: Can We Reduce It?.
73:2803-2805.
2019
-
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial..
73:2819-2828.
2019
-
Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease..
73:2806-2815.
2019
-
Deprescribing in Older Adults With Cardiovascular Disease..
73:2584-2595.
2019
-
10-Year Risk Equations for Incident Heart Failure in the General Population..
73:2388-2397.
2019
-
Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery..
73:2487-2489.
2019
-
Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation..
73:2427-2435.
2019
-
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction..
73:2365-2383.
2019
-
Renal Dysfunction: The Wake-Up Alarm for Chronic Vascular Disease..
73:2251-2252.
2019
-
Reply: hs-cTnI in Stable Chest Pain..
73:2121-2122.
2019
-
Age, STEMI, and Cardiogenic Shock: Never Too Old for PCI?.
73:1901-1904.
2019
-
Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction..
73:1919-1927.
2019
-
Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:1990-1998.
2019
-
RAAS Inhibition to Prevent GI Bleeding: Another Reason to Do the Right Thing..
73:1779-1780.
2019
-
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:e81-e192.
2019
-
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:1494-1563.
2019
-
Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis..
73:1430-1443.
2019
-
Interventional Therapy Versus Medical Therapy for Secundum Atrial Septal Defect: A Systematic Review (Part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:1579-1595.
2019
-
Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
73:1564-1578.
2019
-
Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients..
73:1250-1260.
2019
-
Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry..
73:1135-1146.
2019
-
Outpatient Intravenous Diuretic Therapy for Heart Failure in the United States..
73:1101-1103.
2019
-
Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel..
73:1059-1077.
2019
-
Reply: Intravenous Drug Use-Associated Endocarditis Complicating Research of Antibiotic Prophylaxis and Guideline Recommendations..
73:985-986.
2019
-
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease..
73:893-902.
2019
-
Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease..
73:727-732.
2019
-
Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review..
73:602-611.
2019
-
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons..
73:488-516.
2019
-
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial..
73:387-396.
2019
-
Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment..
73:444-453.
2019
-
Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain..
73:251-260.
2019
-
Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft..
73:131-133.
2019
-
High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction..
73:177-186.
2019
-
Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection..
73:58-66.
2019
-
Fostering New Leaders and Advancing Diversity and Inclusion Are Key to Achieving ACC Vision..
73:110-112.
2019
-
New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review..
73:70-88.
2019
-
Biomarkers for the Prevention of Heart Failure: Are We There Yet?.
72:3255-3258.
2018
-
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial..
72:3274-3284.
2018
-
Disrupting Fellow Education Through Group Texting: WhatsApp in Fellow Education?.
72:3366-3369.
2018
-
Reprint of: Prevention and Control of Hypertension: JACC Health Promotion Series..
72:2996-3011.
2018
-
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients..
72:2687-2696.
2018
-
Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry..
72:2701-2711.
2018
-
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure..
72:2551-2562.
2018
-
Translating the Translation: What Clinicians Should Know About the Fourth Universal Definition of Myocardial Infarction..
72:2668-2670.
2018
-
Antibiotic Prophylaxis and Incidence of Endocarditis Before and After the 2007 AHA Recommendations..
72:2443-2454.
2018
-
Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation..
72:2408-2409.
2018
-
Improving Diversity and Inclusion in Cardiology at the State Level..
72:2265-2268.
2018
-
Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care..
72:1923-1925.
2018
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
72:e91-e220.
2018
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
72:1677-1749.
2018
-
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial..
72:1563-1572.
2018
-
Is Off-Pump CABG Off Base?.
72:1487-1489.
2018
-
Positive Pressure Ventilation in the Cardiac Intensive Care Unit..
72:1532-1553.
2018
-
Prevention and Control of Hypertension: JACC Health Promotion Series..
72:1278-1293.
2018
-
Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization..
72:999-1011.
2018
-
Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse..
72:823-834.
2018
-
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy..
72:721-733.
2018
-
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial..
72:636-645.
2018
-
Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry..
72:351-366.
2018
-
Transcatheter Aortic Valve Replacement of Failed Surgically Implanted Bioprostheses: The STS/ACC Registry..
72:370-382.
2018
-
Understanding and Targeting Inflammation in Acute Myocardial Infarction: An Elusive Goal..
72:199-201.
2018
-
Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?.
72:41-44.
2018
-
Cardiovascular Diseases in India Compared With the United States..
72:79-95.
2018
-
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed..
72:125-126.
2018
-
Geriatric Cardiology: Two Decades of Progress and Strategy for the Future..
71:2970-2973.
2018
-
Unraveling the Mystery of Troponin Elevation in Heart Failure..
71:2917-2918.
2018
-
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways..
71:2829-2855.
2018
-
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways..
71:e283-e351.
2018
-
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways..
71:2811-2828.
2018
-
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement..
71:2717-2726.
2018
-
Effect of Lowering Home Blood Pressure on Subclinical Cardiovascular Disease in Masked Uncontrolled Hypertension..
71:2858-2859.
2018
-
Home-Time After Discharge Among Patients Hospitalized With Heart Failure..
71:2643-2652.
2018
-
Implications of High-Sensitivity Troponin Testing: Learning From Those Who Came Before Us..
71:2625-2627.
2018
-
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care..
71:2680-2690.
2018
-
The Call for Precision Health Trials in Older Adults: One Size Does Not Fit All..
71:2537-2539.
2018
-
Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease..
71:2468-2486.
2018
-
Arthur J. Moss, MD: In Memoriam..
71:2376-2377.
2018
-
Coronary Artery Disease in Patients ≥80 Years of Age..
71:2015-2040.
2018
-
Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future..
71:1921-1936.
2018
-
Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies..
71:1945-1946.
2018
-
Lack of Association Between Heart Failure and Incident Cancer..
71:1501-1510.
2018
-
The Role of Salt Reduction in the Management of Hypertension..
71:1597-1598.
2018
-
Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes..
71:1379-1390.
2018
-
Digoxin and Mortality in Patients With Atrial Fibrillation..
71:1063-1074.
2018
-
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials..
71:1021-1034.
2018
-
ACC Appropriate Use Criteria Methodology: 2018 Update: A Report of the American College of Cardiology Appropriate Use Criteria Task Force..
71:935-948.
2018
-
Reply: Graphing Ratio Measures on Forest Plot..
71:586.
2018
-
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory..
71:443-453.
2018
-
Antithrombotic Therapy in Peripheral Artery Disease: Generating and Translating Evidence Into Practice..
71:352-362.
2018
-
Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block..
71:306-317.
2018
-
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways..
71:201-230.
2018
-
Reply: Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease..
71:106-107.
2018
-
Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease: Sharing the EXCELlence..
70:3123-3126.
2017
-
The Future Role of the United States in Global Health: Emphasis on Cardiovascular Disease..
70:3140-3156.
2017
-
Isolated Tricuspid Valve Surgery..
70:2961-2963.
2017
-
ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons..
70:2566-2598.
2017
-
Change Is Not Always Good..
70:2501-2503.
2017
-
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes..
70:2476-2486.
2017
-
2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways..
70:2421-2449.
2017
-
Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report..
70:2315-2327.
2017
-
Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities..
70:2097-2098.
2017
-
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease..
70:1689-1700.
2017
-
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons..
70:1647-1672.
2017
-
A Natural Biomarker Deserving Attention: Gasping Following Primary Cardiac Arrest..
70:1477-1478.
2017
-
Diversity Matters..
70:1525-1529.
2017
-
Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?.
70:1463-1466.
2017
-
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry..
70:1325-1335.
2017
-
How Medicine Has Changed the End of Life for Patients With Cardiovascular Disease..
70:1276-1289.
2017
-
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards..
70:1029-1095.
2017
-
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease..
70:813-826.
2017
-
Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study..
70:715-724.
2017
-
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
70:620-663.
2017
-
Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
70:664-679.
2017
-
Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison..
70:439-450.
2017
-
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial..
70:331-341.
2017
-
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
70:252-289.
2017
-
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015..
70:1-25.
2017
-
Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry..
70:29-41.
2017
-
Door-to-Furosemide Therapy in the ED: New Quality Metric or Just a Piece of the Puzzle?.
69:3052-3054.
2017
-
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial..
69:3029-3039.
2017
-
Low-Hanging Fruit for a Healthy Old Age..
69:3027-3028.
2017
-
2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee..
69:2977-3001.
2017
-
Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States..
69:2913-2924.
2017
-
When Less Is Not More..
69:2791-2793.
2017
-
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?.
69:2542-2550.
2017
-
New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation..
69:2485-2487.
2017
-
Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up..
69:2369-2379.
2017
-
Navigating Choices Among a Sea of Comorbidities..
69:2380-2382.
2017
-
Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial..
69:2304-2313.
2017
-
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons..
69:2212-2241.
2017
-
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease..
69:2054-2063.
2017
-
Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation..
69:1683-1691.
2017
-
Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial..
69:1577-1587.
2017
-
Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials..
69:1549-1559.
2017
-
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
69:e71-e126.
2017
-
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
69:1465-1508.
2017
-
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure..
69:1399-1406.
2017
-
Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries..
69:1424-1426.
2017
-
Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries..
69:1427-1450.
2017
-
2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
69:1215-1230.
2017
-
2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents..
69:1313-1346.
2017
-
Adherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population..
69:1116-1125.
2017
-
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention..
69:911-921.
2017
-
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force..
69:871-898.
2017
-
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease..
69:823-836.
2017
-
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
69:712-744.
2017
-
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative..
69:679-691.
2017
-
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons..
69:570-591.
2017
-
Changes in the Professional Lives of Cardiologists Over 2 Decades..
69:452-462.
2017
-
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications..
69:437-451.
2017
-
Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?.
69:420-422.
2017
-
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial..
69:395-403.
2017
-
Misdiagnosis of cardiac amyloidosis type by standard immunohistochemistry.
69:826-826.
2017
-
Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014..
68:2733-2744.
2016
-
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry..
68:2597-2604.
2016
-
Determining When to Add Nonstatin Therapy: A Quantitative Approach..
68:2412-2421.
2016
-
Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine..
68:2454-2464.
2016
-
"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX Findings..
68:2385-2387.
2016
-
Multicenter Cardiovascular Studies and Trials: Lessons Learned From 35 Years of Productive Collaboration..
68:2232-2234.
2016
-
TCT-168 Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Left Ventricular Morphology and Cardiac Function: A Collaborative Patient-Level Pooled Analysis from 9 Randomized Trials..
68:B69.
2016
-
TCT-2 Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials..
68:B1.
2016
-
TCT-24 Global cVAD Registry: A global initiative in percutaneous circulatory support From the cVAD Steering Committee on behalf of all cVAD Investigators..
68:B10.
2016
-
TCT-37 Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results from the Evolut R US Pivotal Study..
68:B16.
2016
-
TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral..
68:B152.
2016
-
TCT-645 Cardiovascular Events and Hospital Resource Utilization Pre and Post Transcatheter Mitral Valve Repair in High Surgical Risk Patients..
68:B262.
2016
-
TCT-78 Incidence and Outcomes of Vascular Complications and Bleeding Events in Patients undergoing TAVR in contemporary U.S. practice: Insights from the STS/ACC TVT Registry®..
68:B32.
2016
-
TCT-80 Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies (STS/ACC TVT) Registry..
68:B33.
2016
-
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease..
68:1898-1907.
2016
-
Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME)..
68:1815-1817.
2016
-
2016 ACC/ASE/ASNC/HRS/SCAI Health Policy Statement on Integrating the Healthcare Enterprise..
68:1348-1364.
2016
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
68:1082-1115.
2016
-
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
68:1116-1139.
2016
-
Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation..
68:1144-1146.
2016
-
The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure..
68:977-978.
2016
-
A Series of Unhealthy Developments: The Multiple Facets of Cardiovascular Risk Factors in China..
68:834-835.
2016
-
Searching for Adherence: Can We Fulfill the Promise of Evidence-Based Medicines?.
68:802-804.
2016
-
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction..
68:715-723.
2016
-
Reply: Mean Arterial Pressure Estimation by a Non-Traditional Formula and Fractional Pulse Pressure..
68:669.
2016
-
1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study..
68:435-445.
2016
-
Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank Meeting..
68:517-524.
2016
-
Stroke Prediction in Atrial Fibrillation: Is it Black and White?.
68:471-472.
2016
-
Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study..
68:356-365.
2016
-
Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions..
68:249-251.
2016
-
Reply: Personalize and Optimize Lipid-Lowering Therapies..
68:326.
2016
-
Reply: Pulse Pressure and Cardiovascular Death..
68:132-133.
2016
-
The Genesis, Maturation, and Future of Critical Care Cardiology..
68:67-79.
2016
-
Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?.
67:3025-3026.
2016
-
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF..
67:2888-2899.
2016
-
Intravenous Beta-Blockers for Cardioprotection in STEMI: The Saga Continues..
67:2716-2718.
2016
-
Managing VAD Complications: Our Growth Industry..
67:2769-2771.
2016
-
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement..
67:2565-2574.
2016
-
Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease..
67:2607-2616.
2016
-
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy..
67:2411-2418.
2016
-
Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement..
67:2349-2358.
2016
-
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society..
67:2419-2440.
2016
-
Active Engagement: A Fellow's Guide to Academic Conferences..
67:2306-2309.
2016
-
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS..
67:2224-2234.
2016
-
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial..
67:2135-2144.
2016
-
Educating the Next Generation of Peer Reviewers..
67:2079-2082.
2016
-
Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest..
67:1981-1990.
2016
-
Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials..
67:1674-1683.
2016
-
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
67:e27-e115.
2016
-
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
67:1575-1623.
2016
-
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
67:1572-1574.
2016
-
Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
67:1624-1638.
2016
-
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study..
67:1444-1455.
2016
-
Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study..
67:1412-1422.
2016
-
Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry..
67:1387-1395.
2016
-
Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial..
67:1289-1297.
2016
-
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction..
67:1235-1250.
2016
-
Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States..
67:1129-1140.
2016
-
Pharmacometabolomics Meets Genetics: A "Natural" Clinical Trial of Statin Effects..
67:1211-1213.
2016
-
Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data..
67:963-972.
2016
-
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel..
67:936-947.
2016
-
2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force..
67:853-879.
2016
-
Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE..
67:843-852.
2016
-
Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR..
67:739-747.
2016
-
Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure..
67:780-789.
2016
-
Shedding More Light on Valve Thrombosis After Transcatheter Aortic Valve Replacement..
67:656-658.
2016
-
Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines..
67:724-731.
2016
-
Work Activities and Compensation of Male and Female Cardiologists..
67:529-541.
2016
-
Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry..
67:392-403.
2016
-
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial..
67:353-361.
2016
-
A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure..
67:330-337.
2016
-
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support..
67:291-299.
2016
-
Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines: Insights From the United States and Europe..
67:216-229.
2016
-
When the Cat's Out of the Bag: Searching for Portals of Entry in Infective Endocarditis..
67:159-161.
2016
-
The Management of Acute Chest Pain: What Lies Beyond the Emergency Department Doors?.
67:27-28.
2016
-
Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry..
66:2813-2823.
2015
-
Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II..
66:2844-2854.
2015
-
Reply: Echocardiographic Substrate for Biventricular Pacing..
66:2915-2916.
2015
-
2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion)..
66:2767-2802.
2015
-
Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease..
66:2618-2629.
2015
-
Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya..
66:2550-2560.
2015
-
Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial..
66:2271-2281.
2015
-
Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM..
66:2315-2323.
2015
-
Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH..
66:2092-2100.
2015
-
Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells..
66:2038-2047.
2015
-
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study..
66:1747-1761.
2015
-
Reply: Era of Change in Sites of Service for Peripheral Vascular Intervention Requires New Ways to Look at Costs..
66:1743-1744.
2015
-
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery..
66:1327-1334.
2015
-
Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation..
66:1350-1360.
2015
-
Pediatric Appropriate Use Criteria Implementation Project: A Multicenter Outpatient Echocardiography Quality Initiative..
66:1132-1140.
2015
-
Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry..
66:917-926.
2015
-
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial..
66:777-787.
2015
-
Identification of Typical Left Bundle Branch Block Contraction by Strain Echocardiography Is Additive to Electrocardiography in Prediction of Long-Term Outcome After Cardiac Resynchronization Therapy..
66:631-641.
2015
-
Task Force 8: Pediatric Cardiology Fellowship Training in Research and Scholarly Activity..
66:740-747.
2015
-
The Role of Sodium and Chloride in Heart Failure: Does It Take Two to Tango?.
66:667-669.
2015
-
Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation..
66:616-627.
2015
-
A Company of Equals: Success Through Friendship in Fellowship..
66:589-591.
2015
-
Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients..
66:547-557.
2015
-
Isolated Noncompaction of the Left Ventricle in Adults..
66:578-585.
2015
-
The Early Invasive Strategy in Acute Coronary Syndromes: Should the Guideline Recommendations Be Revisited?.
66:521-523.
2015
-
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)..
66:403-469.
2015
-
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium..
66:278-307.
2015
-
RESPONSE: Are We Committed to Training Fellows in Clinical Investigation?.
66:326-327.
2015
-
Reply: Interpreting Blood Pressure in Young Adults..
66:330-331.
2015
-
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement..
66:113-121.
2015
-
Reply: Mode of Death Prevention by Serelaxin..
66:99.
2015
-
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level..
65:2739-2746.
2015
-
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort..
65:2691-2698.
2015
-
The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients..
65:2601-2610.
2015
-
A call for collaboration: the evolving heart failure apprenticeship network..
65:2348-2351.
2015
-
Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States..
65:2079-2088.
2015
-
Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke..
65:1964-1972.
2015
-
Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension..
65:1998-2038.
2015
-
COCATS 4 Task Force 13: Training in Critical Care Cardiology..
65:1877-1886.
2015
-
COCATS 4 Task Force 5: Training in Echocardiography..
65:1786-1799.
2015
-
Patient selection in heart failure with preserved ejection fraction clinical trials..
65:1668-1682.
2015
-
Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all..
65:1633-1639.
2015
-
Cardiovascular drug development: is it dead or just hibernating?.
65:1567-1582.
2015
-
Platelet activation and pneumonia: is soluble p-selectin the right marker?.
65:1492-1493.
2015
-
Practical management of anticoagulation in patients with atrial fibrillation..
65:1340-1360.
2015
-
Reply: applying cluster analysis to data of previously published chronic heart failure trials: systems biology and clinical phenotypes of heart failure syndrome..
65:1270-1271.
2015
-
Reply: considerations for drug development for heart failure..
65:1061-1062.
2015
-
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)..
65:931-941.
2015
-
Same-day discharge and risks of mortality and readmission after elective ICD placement for primary prevention..
65:955-957.
2015
-
Trends in settings for peripheral vascular intervention and the effect of changes in the outpatient prospective payment system..
65:920-927.
2015
-
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study..
65:465-476.
2015
-
Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study..
65:327-335.
2015
-
Cost-effectiveness of revascularization strategies: the ASCERT study..
65:1-11.
2015
-
Costs associated with health care-associated infections in cardiac surgery..
65:15-23.
2015
-
Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)..
65:103-105.
2015
-
Cardiovascular disease mortality in Asian Americans..
64:2486-2494.
2014
-
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines..
64:e77-137.
2014
-
Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry..
64:2183-2192.
2014
-
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction..
64:2281-2293.
2014
-
ACC/AHA/AACVPR/AAFP/ANA concepts for clinician-patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
64:2133-2145.
2014
-
ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography..
64:2039-2060.
2014
-
Impact of initial shunt type on cardiac size and function in children with single right ventricle anomalies before the Fontan procedure: the single ventricle reconstruction extension trial..
64:2026-2035.
2014
-
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
64:1929-1949.
2014
-
Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients..
64:1968-1969.
2014
-
Clinical implications of chronic heart failure phenotypes defined by cluster analysis..
64:1765-1774.
2014
-
N-terminal pro-B-type natriuretic peptide: a risk predictor for all..
64:1798-1800.
2014
-
Another biomarker for risk assessment in acute myocardial infarction?.
64:1708-1710.
2014
-
Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study..
64:1669-1678.
2014
-
Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial..
64:1541-1550.
2014
-
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study..
64:1591-1598.
2014
-
Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized heart failure..
64:1599-1601.
2014
-
An innovator ahead of her time..
64:1527-1529.
2014
-
The changing landscape of advanced heart failure therapeutics..
64:1416-1417.
2014
-
Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis..
64:1323-1334.
2014
-
Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy..
64:971-981.
2014
-
Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals..
64:811-819.
2014
-
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry..
64:797-807.
2014
-
Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation..
64:710-721.
2014
-
Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study..
64:541-549.
2014
-
Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]..
64:553-561.
2014
-
Management practices and major infections after cardiac surgery..
64:372-381.
2014
-
Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry..
64:256-264.
2014
-
Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair..
64:182-192.
2014
-
On fibrosis, prognosis, and the unique role of CMR: a paradigm shift from "bright is dead" to "bright is bad"..
64:155-157.
2014
-
Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study..
64:172-181.
2014
-
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
63:2960-2984.
2014
-
Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)..
63:2702-2708.
2014
-
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee..
63:2591-2623.
2014
-
Trends in referral to cardiac rehabilitation after myocardial infarction: data from the National Cardiovascular Data Registry 2007 to 2012..
63:2582-2583.
2014
-
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)..
63:2560-2568.
2014
-
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease..
63:2421-2428.
2014
-
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards..
63:2323-2334.
2014
-
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines..
63:2304-2322.
2014
-
We need to do better for patients with non-ST-segment elevation acute coronary syndrome who are managed without revascularization..
63:2258-2260.
2014
-
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes..
63:2141-2147.
2014
-
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery..
63:1972-1981.
2014
-
Smarter deployment of implantable cardioverter-defibrillators in nonischemic cardiomyopathy: feasible or mythical?.
63:1890-1891.
2014
-
Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program..
63:1796-1803.
2014
-
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention..
63:1700-1702.
2014
-
Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)..
63:1500-1509.
2014
-
Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve)..
63:1522-1528.
2014
-
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial..
63:1493-1499.
2014
-
Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011..
63:1395-1404.
2014
-
Isn't it about time we learned how to use blood transfusion in patients with ischemic heart disease?.
63:1297-1299.
2014
-
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)..
63:1190-1197.
2014
-
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries..
63:1123-1133.
2014
-
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)..
63:1082-1087.
2014
-
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)..
63:1048-1057.
2014
-
Impact of academic year timing on percutaneous coronary intervention outcomes at training institutions..
63:1025-1026.
2014
-
Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data..
63:853-871.
2014
-
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)..
63:891-900.
2014
-
Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients..
63:880-888.
2014
-
Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry)..
63:788-796.
2014
-
Endpoints for diuresis: are we there yet?.
63:838-839.
2014
-
Frailty assessment in the cardiovascular care of older adults..
63:747-762.
2014
-
ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 health policy statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee..
63:698-721.
2014
-
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance..
63:722-745.
2014
-
Applying the evidence in coronary disease secondary prevention: a call to action..
63:547-548.
2014
-
Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology..
63:457-459.
2014
-
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons..
63:380-406.
2014
-
Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease)..
63:251-258.
2014
-
Update on the American Board of Internal Medicine Maintenance of Certification Program: a report of the American College of Cardiology's Educational Quality Review Board..
63:92-100.
2014
-
Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events..
62:2349-2359.
2013
-
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding..
62:2261-2273.
2013
-
Cardiovascular care facts: a report from the national cardiovascular data registry: 2011..
62:1931-1947.
2013
-
Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization..
62:2010-2019.
2013
-
Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial..
62:2028-2029.
2013
-
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)..
62:1845-1854.
2013
-
Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes)..
62:1580-1584.
2013
-
Reply: Higher N-terminal Pro-B-type natriuretic peptide may be related to very different conditions..
62:1635-1636.
2013
-
Natriuretic peptides and primary prevention: the new world?.
62:1373-1375.
2013
-
Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events..
62:1267-1276.
2013
-
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers..
62:1290-1297.
2013
-
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure)..
62:1177-1183.
2013
-
Right, but not left, bundle branch block is associated with large anteroseptal scar..
62:959-967.
2013
-
In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry)..
62:692-696.
2013
-
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients..
62:577-583.
2013
-
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study..
62:505-512.
2013
-
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve)..
62:418-430.
2013
-
Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 Medicare beneficiaries..
62:439-446.
2013
-
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation..
62:317-328.
2013
-
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures)..
62:357-396.
2013
-
Comparison of cardiac magnetic resonance and computed tomography stress-rest perfusion imaging for detection of coronary artery disease..
62:353-354.
2013
-
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends..
62:242-251.
2013
-
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction)..
62:150-160.
2013
-
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves)..
61:2514-2521.
2013
-
Cardiohepatic interactions in heart failure: an overview and clinical implications..
61:2397-2405.
2013
-
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
61:e179-e347.
2013
-
HIV and cardiovascular disease in sub-Saharan Africa: the Sutton Law as applied to global health..
61:2395.
2013
-
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)..
61:2274-2284.
2013
-
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force..
61:2207-2231.
2013
-
2013 appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology..
61:2199-2206.
2013
-
Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status..
61:2130-2138.
2013
-
Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)..
61:2161-2168.
2013
-
Triple antithrombotic therapy with prasugrel in the stented patient: concern for more bleeding..
61:2067-2069.
2013
-
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial..
61:1998-2006.
2013
-
Reply: To PMID 23062539..
61:2025-2026.
2013
-
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure..
61:1973-1981.
2013
-
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction..
61:1860-1870.
2013
-
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines..
61:1935-1944.
2013
-
Standardized cardiovascular data for clinical research, registries, and patient care: a report from the Data Standards Workgroup of the National Cardiovascular Research Infrastructure project..
61:1835-1846.
2013
-
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
61:1555-1570.
2013
-
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes..
61:1461-1463.
2013
-
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance..
61:1318-1368.
2013
-
Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force..
61:1305-1317.
2013
-
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards)..
61:992-1025.
2013
-
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis..
61:957-970.
2013
-
Patient- and trial-specific barriers to participation in cardiovascular randomized clinical trials..
61:762-769.
2013
-
Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease..
61:714-722.
2013
-
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)..
61:651-658.
2013
-
Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study..
61:635-642.
2013
-
Targeting lifestyle change in patients with depression..
61:631-634.
2013
-
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial..
61:571-579.
2013
-
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
61:e78-e140.
2013
-
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
61:485-510.
2013
-
Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score..
61:313-321.
2013
-
Reply: To PMID 22954239..
61:388.
2013
-
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
61:213-265.
2013
-
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes..
61:196-206.
2013
-
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry..
61:176-184.
2013
-
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction..
61:35-40.
2013
-
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
60:2564-2603.
2012
-
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
60:e44-e164.
2012
-
Can we prevent heart failure with exercise?.
60:2548-2549.
2012
-
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents..
60:2427-2463.
2012
-
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction..
60:2296-2304.
2012
-
Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008..
60:2280-2289.
2012
-
Subcutaneous B-type natriuretic peptide for treatment of heart failure: a dying therapy reborn?.
60:2313-2315.
2012
-
Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008..
60:2230-2236.
2012
-
A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011..
60:2017-2031.
2012
-
Novel insights into beta-blocker therapy for long QT syndromes..
60:2100-2102.
2012
-
Appropriate use criteria to reduce underuse and overuse: striking the right balance..
60:1885-1887.
2012
-
Relation between volume of exercise and clinical outcomes in patients with heart failure..
60:1899-1905.
2012
-
Ramping up evidence-based ventricular assist device care..
60:1776-1777.
2012
-
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery..
60:1623-1630.
2012
-
Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry..
60:1577-1578.
2012
-
Surgical approaches to mitral regurgitation..
60:1315-1322.
2012
-
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document..
60:1438-1454.
2012
-
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
60:1297-1313.
2012
-
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community..
60:1249-1256.
2012
-
Contemporary results for proximal aortic replacement in North America..
60:1156-1162.
2012
-
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study..
60:1053-1063.
2012
-
Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database..
60:971-977.
2012
-
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!.
60:951-956.
2012
-
Rethinking stable ischemic heart disease: is this the beginning of a new era?.
60:957-959.
2012
-
Standardized reporting criteria for studies evaluating suspected acute heart failure syndromes in the emergency department..
60:822-832.
2012
-
Hydroxychloroquine: a treatable cause of cardiomyopathy..
60:786.
2012
-
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute..
60:569-580.
2012
-
HRS/ACCF expert consensus statement on pacemaker device and mode selection..
60:682-703.
2012
-
Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?.
60:546-547.
2012
-
Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation..
60:408-420.
2012
-
Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis..
60:388-396.
2012
-
ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS/SVU [corrected] 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation appropriate use criteria task force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, Society for Vascular Surgery, [corrected] and Society for Vascular Ultrasound. [corrected]..
60:242-276.
2012
-
Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial..
60:208-215.
2012
-
Clinical application of cardiovascular pharmacogenetics..
60:9-20.
2012
-
Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients..
60:44-51.
2012
-
2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine..
59:2221-2305.
2012
-
Diuretics and ultrafiltration in acute decompensated heart failure..
59:2145-2153.
2012
-
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons..
59:1995-2027.
2012
-
The changing epidemiology of infective endocarditis: the paradox of prophylaxis in the current and future eras..
59:1977-1978.
2012
-
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry..
59:1861-1869.
2012
-
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program..
59:1785-1795.
2012
-
Developing an action plan for patient radiation safety in adult cardiovascular medicine: proceedings from the Duke University Clinical Research Institute/American College of Cardiology Foundation/American Heart Association Think Tank held on February 28, 2011..
59:1833-1847.
2012
-
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow..
59:1441-1448.
2012
-
Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial..
59:1312-1319.
2012
-
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement..
59:1200-1254.
2012
-
Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease..
59:891-900.
2012
-
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy..
59:923-929.
2012
-
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography..
59:857-881.
2012
-
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008..
59:648-654.
2012
-
Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility?.
59:644-647.
2012
-
Differences in treatment patterns and outcomes between Hispanics and non-Hispanic Whites treated for ST-segment elevation myocardial infarction: results from the NCDR ACTION Registry-GWTG..
59:630-631.
2012
-
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease)..
59:462-474.
2012
-
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease)..
59:294-357.
2012
-
Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
59:289-290.
2012
-
Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study..
59:130-139.
2012
-
Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States..
59:105-112.
2012
-
Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry)..
58:2642-2650.
2011
-
The role of platelet function testing and genotyping in the stented patient treated with clopidogrel..
58:2701-2702.
2011
-
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons..
58:e123-e210.
2011
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions..
58:e44-122.
2011
-
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry..
58:2322-2328.
2011
-
Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database..
58:1859-1869.
2011
-
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?.
58:1760-1765.
2011
-
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial)..
58:1557-1565.
2011
-
Trade-offs and toss-ups: making revascularization decisions in carotid artery disease..
58:1566-1568.
2011
-
ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures..
58:1517-1538.
2011
-
Cutaneous clopidogrel hypersensitivity: give steroids and do not stop the clopidogrel..
58:1455-1456.
2011
-
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention..
58:1485-1496.
2011
-
Payment source, quality of care, and outcomes in patients hospitalized with heart failure..
58:1465-1471.
2011
-
ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee..
58:1287-1307.
2011
-
Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease..
58:1077-1079.
2011
-
Device therapy in heart failure patients with chronic kidney disease..
58:889-896.
2011
-
Influence of global region on outcomes in heart failure β-blocker trials..
58:915-922.
2011
-
Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography..
58:801-809.
2011
-
The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program..
58:637-644.
2011
-
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement..
58:316-336.
2011
-
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards..
58:202-222.
2011
-
We need further studies for the development of "optimized antiplatelet therapy" based on ethnicity..
58:198.
2011
-
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise..
57:2317-2327.
2011
-
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension..
57:2037-2114.
2011
-
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)..
57:1899-1907.
2011
-
Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: an angiographic substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial..
57:1867-1873.
2011
-
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)..
57:1890-1898.
2011
-
Cardiac care for older adults. Time for a new paradigm..
57:1801-1810.
2011
-
The acute hemodynamic effects of MitraClip therapy..
57:1658-1665.
2011
-
The privilege of self-regulation: the role of appropriate use criteria..
57:1557-1559.
2011
-
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association..
57:1404-1423.
2011
-
ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians..
57:1126-1166.
2011
-
Cardiovascular events in patients with fabry disease natural history data from the fabry registry..
57:1093-1099.
2011
-
Systematic review of the incidence of sudden cardiac death in the United States..
57:794-801.
2011
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial..
57:672-684.
2011
-
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure..
57:418-423.
2011
-
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium..
57:253-269.
2011
-
Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis..
57:138-146.
2011
-
Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease..
57:86-92.
2011
-
Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5..
56:2021-2030.
2010
-
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance..
56:1864-1894.
2010
-
Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery..
56:1668-1676.
2010
-
Combination of loop diuretics with thiazide-type diuretics in heart failure..
56:1527-1534.
2010
-
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies..
56:1552-1563.
2010
-
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy..
56:1456-1462.
2010
-
Patterns of cardiac stress testing after revascularization in community practice..
56:1328-1334.
2010
-
Testosterone therapy in women with heart failure "why can't a woman be more like a man?"..
56:1317-1319.
2010
-
Coenzyme Q10 and statins in heart failure: the dog that didn't bark..
56:1205-1206.
2010
-
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications..
56:1071-1078.
2010
-
Biomarkers in stroke: when will they impact care?.
56:1054-1055.
2010
-
Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study..
56:1017-1023.
2010
-
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate..
56:919-933.
2010
-
Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study..
56:890-896.
2010
-
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial..
56:692-699.
2010
-
President's page: The ACC encourages multi-pronged approach to radiation safety..
56:522-524.
2010
-
STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment..
56:490-498.
2010
-
Is rehospitalization after heart failure admission a marker of poor quality? Time for re-evaluation..
56:369-371.
2010
-
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities..
56:343-351.
2010
-
Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease..
56:278-287.
2010
-
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention..
56:254-263.
2010
-
Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study..
56:185-193.
2010
-
Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%..
56:206-214.
2010
-
Genotyping: one piece of the puzzle to personalize antiplatelet therapy..
56:112-116.
2010
-
The long and winding road to warfarin pharmacogenetic testing..
55:2813-2815.
2010
-
A risk score to predict bleeding in patients with acute coronary syndromes..
55:2556-2566.
2010
-
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents..
55:2663-2699.
2010
-
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents..
55:2614-2662.
2010
-
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry..
55:1923-1932.
2010
-
Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study..
55:1803-1810.
2010
-
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients..
55:1826-1834.
2010
-
Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation..
55:1796-1802.
2010
-
ACCF/AHA 2010 Position Statement on Composite Measures for Healthcare Performance Assessment: a report of American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop a Position Statement on Composite Measures)..
55:1755-1766.
2010
-
ST-segment resolution and outcome in myocardial infarction..
55:1646-1647.
2010
-
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial..
55:1416-1424.
2010
-
Biomarker bonanza?.
55:1197-1199.
2010
-
Cardiac computed tomographic angiography what's the prognosis?.
55:1029-1031.
2010
-
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score..
55:872-878.
2010
-
No laughing matter..
55:836.
2010
-
When can noninferior be superior? The multidimensional nature of clinical decision-making calls for innovative approaches to clinical trials..
55:555-557.
2010
-
A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria..
55:156-162.
2010
-
Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications..
55:1-16.
2009
-
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures..
54:2261-2276.
2009
-
The SLCO1B1*5 genetic variant is associated with statin-induced side effects..
54:1609-1616.
2009
-
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial..
54:1293-1302.
2009
-
Quality of care for atrial fibrillation among patients hospitalized for heart failure..
54:1280-1289.
2009
-
ACC 2009 survey results and recommendations: Addressing the cardiology workforce crisis A report of the ACC board of trustees workforce task force..
54:1195-1208.
2009
-
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation..
54:1089-1095.
2009
-
Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort..
54:686-694.
2009
-
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program..
54:515-521.
2009
-
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial..
54:468-476.
2009
-
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial..
54:477-486.
2009
-
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device..
54:312-321.
2009
-
Dual renin-angiotensin system blockade in heart failure..
54:278.
2009
-
Why are (only) some infarcted hearts arrhythmogenic?.
54:174-175.
2009
-
End points for clinical trials in acute heart failure syndromes..
53:2248-2258.
2009
-
Nebivolol in older adults with heart failure: reduced rates for seniors?.
53:2159-2161.
2009
-
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial..
53:1965-1972.
2009
-
Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry..
53:1629-1641.
2009
-
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention..
53:1503-1509.
2009
-
Continuous ST-segment monitoring in contemporary acute coronary syndrome patients: the magic of MERLIN-TIMI 36..
53:1422-1424.
2009
-
Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study..
53:1289-1299.
2009
-
Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial..
53:1021-1030.
2009
-
Point-of-care platelet function analysis ready for prime time?.
53:857-859.
2009
-
Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study..
53:648-657.
2009
-
The New York State Primary Angioplasty Registry and procedural volume..
53:580-581.
2009
-
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography..
53:530-553.
2009
-
Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008..
53:514-522.
2009
-
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry..
53:416-422.
2009
-
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry..
53:184-192.
2009
-
Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry..
53:161-166.
2009
-
ACCF 2008 Training Statement on Multimodality Noninvasive Cardiovascular Imaging A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine..
53:125-146.
2009
-
ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR 2008 Health Policy Statement on Structured Reporting in Cardiovascular Imaging..
53:76-90.
2009
-
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction..
53:13-20.
2009
-
Survey results: a decade of change in professional life in cardiology: a 2008 report of the ACC women in cardiology council..
52:2215-2226.
2008
-
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
52:2113-2117.
2008
-
Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program..
52:2000-2007.
2008
-
Saving athletes' lives a reason to find common ground?.
52:1997-1999.
2008
-
ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons..
52:e143-e263.
2008
-
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes..
52:1758-1768.
2008
-
Changing preferences for survival after hospitalization with advanced heart failure..
52:1702-1708.
2008
-
Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial..
52:1724-1732.
2008
-
Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis..
52:1693-1701.
2008
-
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation..
52:1518-1526.
2008
-
Anatomic distribution of the culprit lesion in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: findings from the National Cardiovascular Data Registry..
52:1347-1348.
2008
-
Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial..
52:1076-1083.
2008
-
Obesity and age of first non-ST-segment elevation myocardial infarction..
52:979-985.
2008
-
Mystery of biphasic defibrillation waveform efficacy is it calcium?.
52:836-838.
2008
-
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial..
52:807-814.
2008
-
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol..
52:644-651.
2008
-
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)..
52:551-556.
2008
-
The association of cigarette smoking with enhanced platelet inhibition by clopidogrel..
52:531-533.
2008
-
Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease..
52:387-393.
2008
-
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)..
52:347-356.
2008
-
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program..
52:190-199.
2008
-
A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation..
52:99-107.
2008
-
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction..
52:148-157.
2008
-
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons..
51:e1-62.
2008
-
Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR)..
51:2068-2074.
2008
-
Interpreting the music of drug-eluting stents: halcyon song or albatross dirge?.
51:1854-1856.
2008
-
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both..
51:1865-1871.
2008
-
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial..
51:1734-1741.
2008
-
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry..
51:1675-1684.
2008
-
Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial..
51:1645-1652.
2008
-
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study..
51:1543-1552.
2008
-
Diabetic retinopathy and risk of heart failure..
51:1573-1578.
2008
-
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia..
51:1564-1572.
2008
-
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact..
51:1357-1365.
2008
-
Cardiorenal interactions: insights from the ESCAPE trial..
51:1268-1274.
2008
-
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study..
51:1277-1282.
2008
-
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine..
51:1127-1147.
2008
-
Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes..
51:991-996.
2008
-
Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery..
51:885-892.
2008
-
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration with the Heart Rhythm Society..
51:865-884.
2008
-
President's page: Cardiovascular care in older adults: the ACC and SGC partnership builds new curriculum..
51:672-673.
2008
-
Highlights of the year in JACC 2007..
51:490-512.
2008
-
Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America: Washington, DC, September 16-19, 2007..
51:320-327.
2008
-
Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study..
51:264-270.
2008
-
Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel..
51:261-263.
2008
-
Task Force 12: training in advanced cardiovascular imaging (cardiovascular magnetic resonance [CMR]) endorsed by the Society for Cardiovascular Magnetic Resonance..
51:404-408.
2008
-
Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know?.
51:33-36.
2008
-
Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy..
50:2404-2405.
2007
-
Regression of atherosclerosis with therapeutic antibodies pipe cleaner or pipe dream?.
50:2319-2321.
2007
-
Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity..
50:2243-2248.
2007
-
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial..
50:2117-2124.
2007
-
Physiologic straws in the wind: in which direction do they bend?.
50:2059-2060.
2007
-
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program..
50:1959-1966.
2007
-
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes..
50:1852-1856.
2007
-
Platelet function monitoring in patients with coronary artery disease..
50:1822-1834.
2007
-
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial..
50:1742-1751.
2007
-
Emerging paradigms, platforms, and unifying themes in biomarker science..
50:1777-1780.
2007
-
Iatrogenic left atrial tachycardias: where are we?.
50:1788-1790.
2007
-
The truth and consequences of the COURAGE trial..
50:1598-1603.
2007
-
Early breast cancer therapy and cardiovascular injury..
50:1435-1441.
2007
-
The impact of for-profit hospital status on the care and outcomes of patients with non-ST-segment elevation myocardial infarction: results from the CRUSADE Initiative..
50:1462-1468.
2007
-
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study..
50:1150-1157.
2007
-
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project..
50:1138-1143.
2007
-
ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training..
50:1097-1114.
2007
-
Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options..
50:917-929.
2007
-
Taking cardiovascular genetic association studies to the next level..
50:930-932.
2007
-
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry..
50:768-777.
2007
-
Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial..
50:741-747.
2007
-
Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention..
50:397-405.
2007
-
Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy..
50:432-440.
2007
-
The search for myocardial protection: is there still hope?.
50:406-408.
2007
-
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease..
50:378.
2007
-
ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine..
50:187-204.
2007
-
Thrombosis and drug-eluting stents: an objective appraisal..
50:109-118.
2007
-
ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures)..
50:82-108.
2007
-
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank..
50:40-47.
2007
-
Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis..
50:48-55.
2007
-
Evolving trends in the use of echocardiography: a study of Medicare beneficiaries..
49:2283-2291.
2007
-
Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery..
49:1934-1942.
2007
-
Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative..
49:1790-1797.
2007
-
Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials..
49:1450-1458.
2007
-
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases..
49:1376-1379.
2007
-
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases..
49:1373-1412.
2007
-
Abnormal left ventricular diastolic filling in chronic thromboembolic pulmonary hypertension: true diastolic dysfunction or left ventricular underfilling?.
49:1334-1339.
2007
-
Cardiology and the critical care crisis: a perspective..
49:1279-1282.
2007
-
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial..
49:1362-1368.
2007
-
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update..
49:1230-1250.
2007
-
ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards..
49:830-837.
2007
-
Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?.
49:657-666.
2007
-
Highlights of the Year in JACC 2006..
49:509-527.
2007
-
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial..
48:2440-2447.
2006
-
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study..
48:2186-2191.
2006
-
Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model..
48:2306-2314.
2006
-
Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging..
48:2141-2151.
2006
-
Improving imaging: our professional imperative..
48:2152-2155.
2006
-
Microarrays coming of age in cardiovascular medicine: standards, predictions, and biology..
48:1618-1620.
2006
-
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials..
48:1567-1572.
2006
-
ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology..
48:1475-1497.
2006
-
After fibrinolysis: is cardiac catheterization the answer?.
48:1336-1338.
2006
-
Novel--and "neu"--therapeutic possibilities for heart failure..
48:1448-1450.
2006
-
Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy..
48:1416-1424.
2006
-
Redefining heart failure: the utility of genomics..
48:1289-1298.
2006
-
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy..
48:1146-1154.
2006
-
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers..
48:939-947.
2006
-
Angiotensin-converting enzyme genotype predicts cardiac and autonomic responses to prolonged exercise..
48:523-531.
2006
-
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database..
48:471-477.
2006
-
Using measures of disease progression to determine therapeutic effect: a sirens' song..
48:434-437.
2006
-
Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery..
48:281-286.
2006
-
Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications..
48:227-235.
2006
-
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial..
48:15-20.
2006
-
Prescribing BiDil: is it black and white?.
48:12-14.
2006
-
Beta-blocker use and outcomes among hospitalized heart failure patients..
47:2462-2469.
2006
-
Left atrial size: physiologic determinants and clinical applications..
47:2357-2363.
2006
-
Cardiac function and heart failure..
47:D18-D22.
2006
-
Diagnostic testing..
47:D23-D27.
2006
-
Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST)..
47:2260-2266.
2006
-
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure..
47:2245-2252.
2006
-
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program..
47:1997-2004.
2006
-
Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement..
47:2027-2033.
2006
-
Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging..
47:1630-1638.
2006
-
President's page: making imaging meaningful..
47:1485-1486.
2006
-
ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction?.
47:1339-1345.
2006
-
President's page: a question of quality: why national benchmarking?.
47:1076-1078.
2006
-
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction..
47:951-961.
2006
-
Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure..
47:930-932.
2006
-
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes..
47:809-816.
2006
-
Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) trial..
47:715-718.
2006
-
Task Force 12: training in advanced cardiovascular imaging (cardiovascular magnetic resonance [CMR]): endorsed by the Society for Cardiovascular Magnetic Resonance..
47:910-914.
2006
-
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)..
47:726-733.
2006
-
Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery..
47:635-643.
2006
-
President's page: Collaborative culture key to our success..
47:681-682.
2006
-
Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials..
47:685-686.
2006
-
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study..
47:S36-S43.
2006
-
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes..
47:312-318.
2006
-
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level..
47:338-341.
2006
-
Cardiac rehabilitation, exercise training, and psychosocial risk factors..
47:212.
2006
-
Coming together to achieve quality cardiovascular care..
47:266-267.
2006
-
Highlights of the Year in JACC 2005..
47:184-202.
2006
-
Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients..
47:98-107.
2006
-
President's page: New York 1952 to Atlanta 2006: celebrating the cardiovascular community..
47:203-204.
2006
-
Cardiac resynchronization therapy: Part 1--issues before device implantation..
46:2153-2167.
2005
-
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions..
46:2168-2182.
2005
-
Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure..
46:2298-2304.
2005
-
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial..
46:2329-2334.
2005
-
Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study..
46:2277-2283.
2005
-
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program..
46:2348-2356.
2005
-
New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics..
46:1965-1977.
2005
-
President's page: appropriateness criteria: breaking new ground..
46:2143-2144.
2005
-
Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study..
46:1827-1832.
2005
-
Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study..
46:1820-1826.
2005
-
A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery..
46:1684-1692.
2005
-
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)..
46:1712-1720.
2005
-
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation..
46:1729-1736.
2005
-
Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation..
46:1705-1709.
2005
-
President's page: Prevention's place in cardiology: what the future holds..
46:1777-1778.
2005
-
Prospects for personalized cardiovascular medicine: the impact of genomics..
46:1615-1627.
2005
-
ACCF proposed method for evaluating the appropriateness of cardiovascular imaging..
46:1606-1613.
2005
-
ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association..
46:1587-1605.
2005
-
Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative..
46:1479-1487.
2005
-
The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative..
46:1490-1495.
2005
-
The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries..
46:1536-1540.
2005
-
Economic effects of extended clopidogrel therapy--a word of caution..
46:1376.
2005
-
Enhancing stem cell therapy through genetic modification..
46:1351-1353.
2005
-
President's page: i2 Summit 2006: one-stop shopping for interventionalists..
46:1371-1372.
2005
-
Anemia as a risk factor and therapeutic target in heart failure..
44:959-966.
2004
-
President's page: Cardiology without borders: embracing a healthy global association..
44:1137-1138.
2004
-
Q wave MI vs non Q wave myocardial infarction after thrombolytic therapy. One year prognosis after hospital discharge. A GUSTO I substudy.
29:771-777.
1997
-
Indications for ascending aortic replacement size alone is not enough..
58:585-586.
2011
-
Ongoing myocardial damage in severe heart failure: prognostic usefulness of cardiac troponin T monitoring to identifying high risk patients (Abstract).
43 (Suppl A):226A-226A.
2004
-
Predictors of mortality in patients hospitalized with worsening heart failure: Insights from the ACTIV in CHF Trial.
43 (Suppl A):181A-181A.
2004
-
Grade 3 ischemia on presentation in acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolytic therapy (Abstract).
37 (Suppl A):115 A-115 A.
2001
-
Atrial fibrillation (AF) after coronary artery bypass surgery (CABG). Incidence, importance and cost (Abstract).
31:315 C-315 C.
1998
-
CABG In patients with previous renal failure. Evolution and prognosis (Abstract).
31:314 C-314 C.
1998
-
Coronary artery disease in the young (CABG). The role of smoking (Abstract).
31:315 C-315 C.
1998
-
Diabetes mellitus and coronary artery bypass surgery (CABG). Its importance in the 90´s (Abstract).
31:315 C-2585.
1998
-
Different outcome of patients with sustained monomorphic ventricular tachycardia requiring cardioversion during acute myocardial infarction: Analysis in the GUSTO I Study (Abstract).
31 (Suppl A):2-96 A.
1998
-
Outcome of patients with acute myocardial infarction and bundle branch block in the thrombolytic era: observations from GUSTO (Abstract).
31:105-110.
1998
-
Prognosis and quality of life by electrocardiographic measures of infarct size after thrombolysis. A GUSTO-I substudy (Abstract).
31:315 C-315 C.
1998
-
Mortality, morbidity, resource use and quality of life following Q Vs non-Q-wave infarction and thrombolytic therapy: GUSTO substudy (Abstract).
29:490A-490A.
1997
-
Reciprocal expression of cytochrome oxidase genes during murine myogenesis (Abstract).
21:374A-374A.
1993
-
The human myoglobin promoter directs chamber-specific and transmurally heterogeneous transcription in hearts of transgenic mice (Abstract).
19:102A-102A.
1992
-
Partial coronary occlusion is associated with depletion of tissue oxygen stores (Abstract).
17:36A-36A.
1991
-
Left ventricular end diastolic wall thickness and tissue blood volume during brief ischemia and reperfusion (Abstract).
15:54A-54A.
1990
-
In vivo near infrared monitoring of myocardial oxygenation during ischemia and reperfusion (Abstract).
13:251A-251A.
1989
-
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report.
2021
-
Standardized Team-Based Care for Cardiogenic Shock.
2019
-
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
2014
-
Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry.
2013